atovaquone and proguanil hcl- atovaquone and proguanil hydrochloride tablet, film coated
prasco laboratories - atovaquone (unii: y883p1z2lt) (atovaquone - unii:y883p1z2lt), proguanil hydrochloride (unii: r71y86m0wt) (proguanil - unii:s61k3p7b2v) - atovaquone 250 mg - atovaquone and proguanil hydrochloride tablets are indicated for the prophylaxis of plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. atovaquone and proguanil hydrochloride tablets are indicated for the treatment of acute, uncomplicated p. falciparum malaria. atovaquone and proguanil hydrochloride have been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance. risk summary available data from published literature and postmarketing experience with use of atovaquone and proguanil hydrochloride in pregnant women are insufficient to identify a drug-associated risk for major birth defects, miscarriage, or adverse maternal or fetal outcomes. the proguanil component of atovaquone and proguanil hydrochloride tablets acts to inhibit parasitic dihydrofolate reductase; however, pregnant women and females of reproductive potential should continue fola
atovaquone and proguanil hcl- atovaquone and proguanil hydrochloride tablet, film coated
bryant ranch prepack - atovaquone (unii: y883p1z2lt) (atovaquone - unii:y883p1z2lt), proguanil hydrochloride (unii: r71y86m0wt) (proguanil - unii:s61k3p7b2v) - atovaquone 250 mg - atovaquone and proguanil hydrochloride tablets are indicated for the prophylaxis of plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. atovaquone and proguanil hydrochloride tablets are indicated for the treatment of acute, uncomplicated p. falciparum malaria. atovaquone and proguanil hydrochloride have been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance. risk summary available data from published literature and postmarketing experience with use of atovaquone and proguanil hydrochloride in pregnant women are insufficient to identify a drug-associated risk for major birth defects, miscarriage, or adverse maternal or fetal outcomes. the proguanil component of atovaquone and proguanil hydrochloride tablets acts to inhibit parasitic dihydrofolate reductase; however, pregnant women and females of reproductive potential should continue fola
atovaquone and proguanil hcl- atovaquone and proguanil hydrochloride tablet, film coated
a-s medication solutions - atovaquone (unii: y883p1z2lt) (atovaquone - unii:y883p1z2lt), proguanil hydrochloride (unii: r71y86m0wt) (proguanil - unii:s61k3p7b2v) - atovaquone 250 mg - atovaquone and proguanil hydrochloride tablets are indicated for the prophylaxis of plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. atovaquone and proguanil hydrochloride tablets are indicated for the treatment of acute, uncomplicated p. falciparum malaria. atovaquone and proguanil hydrochloride have been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance. risk summary available data from published literature and postmarketing experience with use of atovaquone and proguanil hydrochloride in pregnant women are insufficient to identify a drug-associated risk for major birth defects, miscarriage, or adverse maternal or fetal outcomes. the proguanil component of atovaquone and proguanil hydrochloride tablets acts to inhibit parasitic dihydrofolate reductase; however, pregnant women and females of reproductive potential should continue fola
lariam 250mg tablets
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - mefloquine - tablet - mefloquine 250 milligram(s) - antiprotozoals
lariam 250mg tablets
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - mefloquine - tablet - mefloquine 250 mg - antiprotozoals
artesunate and mefloquine tablets 100mg + 200mg
cipla limited, india - artesunate , mefloquine - tablets - 100mg + 200mg
mephaquin lactab, 250 mg, coated tablet
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - mefloquine - coated tablet - mefloquine 250 mg - antiprotozoals
artequin-300/375 lactab film-coated tablet
acino pharma ag birsweg 2 liesberg basel ��� land - artesunate 100 mg mefloquine 125 mg - film-coated tablet - mefloquine hydrochloride micronized 1375000 - antimalarial antiprotozoals: plain artemisininand
fansimef
roche products (nz) ltd - mefloquine hydrochloride 250mg; pyrimethamine 500mg; sulfadoxine 25mg - tablet - 250mg/500mg/25mg - active: mefloquine hydrochloride 250mg pyrimethamine 500mg sulfadoxine 25mg
confal 5 tab
lupin - mefloquine hcl. - tab - 250mg - 5